Want to see CLB full AI Analyst Report?
Core Laboratories (CLB) Ratios
Core Laboratories Ratios
CLB's free cash flow for Q3 2026 was $15.63M. For the 2026 fiscal year, CLB's free cash flow was increased by $10.66M and operating cash flow was $4.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.02 | 2.32 | 2.53 | 2.05 | 2.08 |
| Quick Ratio | 1.51 | 1.71 | 1.72 | 1.47 | 1.58 |
| Cash Ratio | 0.21 | 0.20 | 0.17 | 0.15 | 0.20 |
| Solvency Ratio | 0.14 | 0.14 | 0.15 | 0.09 | 0.09 |
| Operating Cash Flow Ratio | 0.35 | 0.58 | 0.28 | 0.24 | 0.40 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -97.14M | $ -106.06M | $ -133.45M | $ -177.70M | $ -230.80M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.28 | 0.31 | 0.37 | 0.38 | 0.43 |
| Debt-to-Equity Ratio | 0.62 | 0.71 | 0.96 | 1.21 | 1.60 |
| Debt-to-Capital Ratio | 0.38 | 0.42 | 0.49 | 0.55 | 0.62 |
| Long-Term Debt-to-Capital Ratio | 0.29 | 0.33 | 0.42 | 0.48 | 0.55 |
| Financial Leverage Ratio | 2.20 | 2.34 | 2.61 | 3.14 | 3.71 |
| Debt Service Coverage Ratio | 5.26 | 4.81 | 4.93 | 4.18 | 5.23 |
| Interest Coverage Ratio | 4.78 | 4.73 | 4.07 | 3.59 | 4.95 |
| Debt to Market Cap | 0.15 | 0.16 | 0.20 | 0.18 | 0.18 |
| Interest Debt Per Share | 3.75 | 4.11 | 4.90 | 5.05 | 5.64 |
| Net Debt to EBITDA | 1.99 | 2.19 | 2.84 | 3.53 | 3.65 |
| Profitability Margins | |||||
| Gross Profit Margin | 17.91% | 16.87% | 18.45% | 16.11% | 17.83% |
| EBIT Margin | 10.72% | 11.18% | 10.72% | 8.48% | 9.63% |
| EBITDA Margin | 13.51% | 14.03% | 13.81% | 11.98% | 13.56% |
| Operating Profit Margin | 9.59% | 11.18% | 10.72% | 8.48% | 9.63% |
| Pretax Profit Margin | 8.72% | 8.82% | 8.08% | 6.12% | 7.68% |
| Net Profit Margin | 5.63% | 5.99% | 7.19% | 3.97% | 4.19% |
| Continuous Operations Profit Margin | 5.77% | 6.14% | 7.26% | 4.01% | 4.29% |
| Net Income Per EBT | 64.64% | 67.98% | 89.00% | 64.94% | 54.63% |
| EBT Per EBIT | 90.90% | 78.88% | 75.42% | 72.14% | 79.78% |
| Return on Assets (ROA) | 5.08% | 5.32% | 6.25% | 3.36% | 3.40% |
| Return on Equity (ROE) | 11.15% | 12.46% | 16.31% | 10.56% | 12.61% |
| Return on Capital Employed (ROCE) | 10.56% | 11.88% | 10.97% | 8.74% | 9.24% |
| Return on Invested Capital (ROIC) | 6.83% | 8.10% | 9.65% | 5.60% | 5.04% |
| Return on Tangible Assets | 6.30% | 6.48% | 7.64% | 4.13% | 4.17% |
| Earnings Yield | 3.98% | 3.87% | 4.45% | 2.07% | 1.92% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.36 | 4.11 | 4.14 | 4.25 | 4.41 |
| Payables Turnover | 11.60 | 12.60 | 12.41 | 8.96 | 13.00 |
| Inventory Turnover | 7.93 | 7.33 | 5.80 | 6.80 | 8.50 |
| Fixed Asset Turnover | 3.42 | 3.41 | 3.32 | 3.11 | 2.73 |
| Asset Turnover | 0.90 | 0.89 | 0.87 | 0.85 | 0.81 |
| Working Capital Turnover Ratio | 4.43 | 3.97 | 4.19 | 4.74 | 5.39 |
| Cash Conversion Cycle | 98.28 | 109.57 | 121.65 | 98.76 | 97.70 |
| Days of Sales Outstanding | 83.74 | 88.74 | 88.11 | 85.79 | 82.85 |
| Days of Inventory Outstanding | 46.02 | 49.79 | 62.95 | 53.70 | 42.92 |
| Days of Payables Outstanding | 31.48 | 28.96 | 29.42 | 40.73 | 28.08 |
| Operating Cycle | 129.76 | 138.53 | 151.07 | 139.49 | 125.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.80 | 1.20 | 0.53 | 0.54 | 0.80 |
| Free Cash Flow Per Share | 0.48 | 0.92 | 0.30 | 0.32 | 0.50 |
| Dividend Paid and CapEx Coverage Ratio | 2.23 | 3.78 | 1.99 | 2.07 | 2.38 |
| Capital Expenditure Coverage Ratio | 2.51 | 4.33 | 2.34 | 2.44 | 2.70 |
| Operating Cash Flow Coverage Ratio | 0.23 | 0.31 | 0.12 | 0.11 | 0.15 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.11 | 0.05 | 0.05 | 0.08 |
| Free Cash Flow Yield | 2.99% | 5.34% | 1.72% | 1.57% | 2.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 23.57 | 25.85 | 22.48 | 48.28 | 52.03 |
| Price-to-Sales (P/S) Ratio | 1.42 | 1.55 | 1.62 | 1.92 | 2.18 |
| Price-to-Book (P/B) Ratio | 2.80 | 3.22 | 3.67 | 5.10 | 6.56 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 33.44 | 18.72 | 58.02 | 63.72 | 44.55 |
| Price-to-Operating Cash Flow Ratio | 20.13 | 14.40 | 33.26 | 37.63 | 28.06 |
| Price-to-Earnings Growth (PEG) Ratio | 15.79 | -1.70 | 0.26 | -20.76 | -0.43 |
| Enterprise Value Multiple | 12.47 | 13.23 | 14.55 | 19.53 | 19.74 |
| Enterprise Value | 886.71M | 972.77M | 1.02B | 1.15B | 1.26B |
| EV to EBITDA | 12.47 | 13.23 | 14.55 | 19.53 | 19.74 |
| EV to Sales | 1.68 | 1.86 | 2.01 | 2.34 | 2.68 |
| EV to Free Cash Flow | 39.78 | 22.43 | 72.11 | 77.76 | 54.65 |
| EV to Operating Cash Flow | 23.95 | 17.25 | 41.34 | 45.93 | 34.42 |
| Tangible Book Value Per Share | 3.43 | 3.24 | 2.64 | 1.77 | 1.16 |
| Shareholders’ Equity Per Share | 5.72 | 5.37 | 4.82 | 3.98 | 3.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.34 | 0.30 | 0.10 | 0.34 | 0.44 |
| Revenue Per Share | 11.32 | 11.17 | 10.92 | 10.57 | 10.22 |
| Net Income Per Share | 0.64 | 0.67 | 0.79 | 0.42 | 0.43 |
| Tax Burden | 0.65 | 0.68 | 0.89 | 0.65 | 0.55 |
| Interest Burden | 0.81 | 0.79 | 0.75 | 0.72 | 0.80 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.08 | 0.07 | 0.08 | 0.08 | 0.09 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.03 | 0.02 | 0.04 |
| Income Quality | 1.22 | 1.75 | 0.67 | 1.27 | 1.81 |
Currency in USD
